Overview

EU/LA Pearl Index Study - Transdermal Contraceptive Patch

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The aim of the present study is to prove efficacy and safety of a new contraceptive patch.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Contraceptive Agents
Ethinyl Estradiol
Femovan
Gestodene